Azitra (AZTR) Capital Leases (2023 - 2025)
Azitra (AZTR) posted Capital Leases of $1479.0 for Q2 2025, down 74.69% on a QoQ basis from $5843.0 in Q1 2025, and down 91.93% year-over-year from $18329.0 in Q2 2024.
Azitra (AZTR) Capital Leases (2023 - 2025) Analysis & Trends
Azitra's Capital Leases history runs 3 years deep, the most recent figure standing at $1479.0 for Q2 2025.
- Quarterly Capital Leases fell 91.93% year-over-year to $1479.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $1479.0 (down 91.93% YoY) and the FY2024 annual result came in at $10105.0, down 61.39% from the prior year.
- Capital Leases was $1479.0 for Q2 2025 at Azitra, down from $5843.0 in the prior quarter.
- Across five years, Capital Leases topped out at $29952.0 in Q3 2023 and bottomed at $1479.0 in Q2 2025.
- A 3-year average of $16054.9 and a median of $16297.5 in 2024 frame the typical range for Capital Leases.
- Annual changes were most pronounced in 2024 — Capital Leases sank 52.37% — and 2025, when it tumbled 91.93%.
- Azitra's Capital Leases stood at $26169.0 in 2023, then slumped by 61.39% to $10105.0 in 2024, then plunged by 85.36% to $1479.0 in 2025.
- Business Quant data shows AZTR's Capital Leases at $1479.0 in Q2 2025, $5843.0 in Q1 2025, and $10105.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Nanobiotix | 1,769.80 Bn | 1,769.74 Bn | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 3 | BeOne Medicines | 473.64 Bn | 468.85 Bn | 1.35 Bn |
| 4 | Vertex Pharmaceuticals | 123.74 Bn | 116.49 Bn | 2.59 Bn |
| 5 | Regeneron Pharmaceuticals | 71.73 Bn | 62.97 Bn | 3.31 Bn |
| 6 | Belite Bio | 62.10 Bn | 62.10 Bn | - |
| 7 | Argenx Se | 54.68 Bn | 49.49 Bn | 1.41 Bn |
| 8 | Alnylam Pharmaceuticals | 38.13 Bn | 35.12 Bn | 959.66 Mn |
| 9 | Revolution Medicines | 36.21 Bn | 36.21 Bn | - |
| 10 | Azitra | 2.03 Mn | 2.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 1,479.00 |
| Mar 31, 2025 | 5,843.00 |
| Dec 31, 2024 | 10,105.00 |
| Sep 30, 2024 | 14,266.00 |
| Jun 30, 2024 | 18,329.00 |
| Mar 31, 2024 | 22,296.00 |
| Dec 31, 2023 | 26,169.00 |
| Sep 30, 2023 | 29,952.00 |